ALLEGRO MICROSYSTEMS INC
For the period ended Mar 28, 2025. Filed May 22, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed May 22, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ALLEGRO MICROSYSTEMS, INC. | |
| By: | /s/ Michael C. Doogue |
| Michael C. Doogue | |
| President, Chief Executive Officer (Principal Executive Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant and the capacities and on the dates indicated. Each person whose signature appears below constitutes and appoints Derek P. D’Antilio and Sharon S. Briansky, and each or any of them, his or her true and lawful attorney-in-fact and agent, each acting alone, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendments or supplements (including post-effective amendments) to this report, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
| Signature | Title | Date |
|---|---|---|
| /s/ Michael C. Doogue | President and Chief Executive Officer (Principal | May 22, 2025 |
| Michael C. Doogue | Executive Officer) and Director | |
| /s/ Derek P. D’Antilio | Chief Financial Officer (Principal Financial Officer) | May 22, 2025 |
| Derek P. D’Antilio | ||
| /s/ Roald G. Webster | Vice President, Chief Accounting Officer | May 22, 2025 |
| Roald G. Webster | ||
| /s/ Yoshihiro (Zen) Suzuki | Chairman of the Board of Directors | May 22, 2025 |
| Yoshihiro (Zen) Suzuki | ||
| /s/ Katsumi Kawashima | Director | May 22, 2025 |
| Katsumi Kawashima | ||
| /s/ Richard Lury | Director | May 22, 2025 |
| Richard Lury | ||
| /s/ Susan Lynch | Director | May 22, 2025 |
| Susan Lynch | ||
| /s/ Joseph Martin | Director | May 22, 2025 |
| Joseph Martin | ||
| /s/ Krishna Palepu | Director | May 22, 2025 |
| Krishna Palepu | ||
| /s/ Mary Puma | Director | May 22, 2025 |
| Mary Puma | ||
| /s/ Jennie Raubacher | Director | May 22, 2025 |
| Jennie Raubacher | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.